Evofem Biosciences Inc (EVFM)

[tdeck]

Definitely its not only this product which they are going to aggressively promote worldwide in July/August but it is also the next product in the pipeline.

https://www.biospace.com/article/releases/evofem-biosciences-completes-phase-2b-amprevence-trial-of-amphora-for-prevention-of-chlamydia-and-gonorrhea-in-women/

The numbers there are staggering, just in the US then when the numbers are extrapolated to the world at large, have a winner already in Phexxi, but, I think more than myself see this as a winner winner chicken dinner opportunity and agree that will end in buyout when that horse it let out of the barn.

Always happens with smaller biotechs especially when they have a number of winners in a sector of the market. Bigger companies can cut costs in every aspect which is why they gobble up these smaller players.

Peace out